Moreau Christelle, Wagner Gerd K, Weber Karin, Guse Andreas H, Potter Barry V L
Wolfson Laboratory of Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, United Kingdom.
J Med Chem. 2006 Aug 24;49(17):5162-76. doi: 10.1021/jm060275a.
A series of nicotinamide hypoxanthine 5'-dinucleotide (NHD+) analogues modified at C-8 (2-5) and 7-deaza-NHD+ were synthesized, and cyclization in the presence of Aplysia ADP-ribosyl cyclase was studied. All 8-substituted NHD+ analogues were converted into their N1-cyclic forms by the enzyme, while in contrast, 7-deaza-NHD+ 17 was hydrolyzed into 7-deazainosine 5'-diphosphoribose (7-deaza-IDPR) 25. Correlations are made showing that the conformation of the NHD+ substrate is the key to successful cyclization. The pharmacological activities of these novel cIDPR derivatives were evaluated in both permeabilized and intact Jurkat T-lymphocytes. The results show that in permeabilized cells both 8-iodo 1g and 8-N3-N1-cIDPR 1d have an activity comparable to that of cADPR, while 8-iodo 1g and 8-phenyl-N1-cIDPR 1c have a small but significant effect in intact cells and can therefore be regarded as membrane-permeant; thus, cIDPR derivatives are emerging as important novel biological tools to study cADPR-mediated Ca2+ release in T-cells.
合成了一系列在C-8(2-5)位修饰的烟酰胺次黄嘌呤5'-二核苷酸(NHD +)类似物和7-脱氮-NHD +,并研究了在海兔ADP-核糖基环化酶存在下的环化反应。所有8-取代的NHD +类似物都被该酶转化为其N1-环化形式,而相比之下,7-脱氮-NHD + 17则水解为7-脱氮肌苷5'-二磷酸核糖(7-脱氮-IDPR)25。研究表明,NHD +底物的构象是成功环化的关键。在透化的和完整的Jurkat T淋巴细胞中评估了这些新型cIDPR衍生物的药理活性。结果表明,在透化细胞中,8-碘代1g和8-N3-N1-cIDPR 1d的活性与cADPR相当,而8-碘代1g和8-苯基-N1-cIDPR 1c在完整细胞中有微小但显著的作用,因此可被视为可透过细胞膜的;因此,cIDPR衍生物正在成为研究T细胞中cADPR介导的Ca2 +释放的重要新型生物学工具。